Association between sitagliptin plus vitamin D3 (VIDPP-4i) use and clinical remission in patients with new-onset type 1 diabetes: a retrospective case-control study

Association between sitagliptin plus vitamin D3 (VIDPP-4i) use and clinical remission in patients with new-onset type 1 diabetes: a retrospective case-control study

ABSTRACT Objective: The occurrence of partial remission (honeymoon phase) in type 1 diabetes (T1D) has been associated with a reduced risk of chronic microvascular complications of diabetes. We have published case reports showing that a combination therapy with the DPP-4 inhibitor sitagliptin plus...

Full description

Bibliographic Details
Main Authors: Marcelo Maia Pinheiro, Felipe Moura Maia Pinheiro, Marcelo Müller de Arruda, Geane Moron Beato, Graciele Alves Corrêa Lima Verde, Georgiana Bianchini, Pedro Rosário Moraes Casalenuovo, Aline Aparecida Agostini Argolo, Lucilene Telles de Souza, Flávia Gomes Pessoa, Thiago Santos Hirose, Eduardo Filgueiras Senra, Camillo Ricordi, Andrea Fabbri, Marco Infante, Susana Nogueira Diniz
Format: Article
Language:English
Published: Brazilian Society of Endocrinology and Metabolism 2023-06-01
Series:Archives of Endocrinology and Metabolism
Subjects:
Cholecalciferol
DPP-4 inhibitor
honeymoon phase
type 1 diabetes
vitamin D
Online Access:http://www.scielo.br/scielo.php?script=sci_arttext&pid=S2359-39972023000500214&lng=en&tlng=en

Internet

http://www.scielo.br/scielo.php?script=sci_arttext&pid=S2359-39972023000500214&lng=en&tlng=en

Similar Items